TY  - JOUR
AU  - Bullón-Vela, Vanessa
AU  - Abete, Itziar
AU  - Zulet, Maria Angeles
AU  - Xu, Yifan
AU  - Martínez-González, Miguel A
AU  - Sayón-Orea, Carmen
AU  - Ruiz-Canela, Miguel
AU  - Toledo, Estefanía
AU  - Sánchez, Vicente Martín
AU  - Estruch, Ramon
AU  - Lamuela-Raventós, Rosa María
AU  - Almanza-Aguilera, Enrique
AU  - Fitó, Montserrat
AU  - Salas-Salvadó, Jordi
AU  - Díaz-López, Andrés
AU  - Tinahones, Francisco J
AU  - Tur, Josep A
AU  - Romaguera, Dora
AU  - Konieczna, Jadwiga
AU  - Pintó, Xavier
AU  - Daimiel, Lidia
AU  - Rodriguez-Mateos, Ana
AU  - Alfredo Martínez, José
PY  - 2020
DO  - 10.3390/molecules25184340
UR  - http://hdl.handle.net/10668/16308
T2  - Molecules (Basel, Switzerland)
AB  - Metabolic syndrome (MetS) components are strongly associated with increased risk of non-alcoholic fatty liver disease (NAFLD) development. Several studies have supported that resveratrol is associated with anti-inflammatory and antioxidant effects on...
LA  - en
KW  - antioxidant
KW  - inflammation
KW  - liver enzymes
KW  - metabolic syndrome
KW  - non-alcoholic fatty liver disease
KW  - resveratrol
KW  - Aged
KW  - Biomarkers
KW  - Cross-Sectional Studies
KW  - Female
KW  - Humans
KW  - Liver
KW  - Male
KW  - Metabolic Syndrome
KW  - Middle Aged
KW  - Models, Statistical
KW  - Myocardium
KW  - Resveratrol
KW  - Risk
TI  - Urinary Resveratrol Metabolites Output: Differential Associations with Cardiometabolic Markers and Liver Enzymes in House-Dwelling Subjects Featuring Metabolic Syndrome.
TY  - research article
VL  - 25
ER  -